Current Strategies in the Treatment of Colorectal Cancer and Non-colorectal Gastrointestinal Cancers 2012

• The importance of predictive and prognostic makers in colorectal cancer beyond kras
• Status of chemotherapy for colorectal cancer
• The role of EGFR inhibitors in combination with chemotherapy
• The data on utilization of alternate angiogenesis inhibitors in colorectal cancer
• Advances in the treatment of pancreatic carcinoma
• Advances in the treatment of esophagogastric carcinoma
• Treatment options for the management of hepatocellular carcinoma
• Multidisciplinary approaches in the management of rectal cancer
• Supportive cancer care options in the era of targeted therapy
• The role of pharmacogenomics and their utility in individualized therapies for colorectal cancer
• Symptom management issues in the era of targeted chemotherapy
• Practice guidelines and its impact on reimbursement issues in the management of gastrointestinal cancers

Current Strategies in the Treatment of Colorectal Cancer and Non-colorectal Gastrointestinal Cancers 2012 brings together radiation oncologists, medical oncologists, gastroenterologists, surgical oncologists, registered nurses, fellows in training, physician assistants, nurse practitioners and pharmacist interested in new developments for treatment of colorectal and non-colorectal gastrointestinal cancers.

Educational Grants
This activity is supported by education grants from:
Genentech BioOncology
sanofi-aventis
Lilly USA, LLC
Bristol-Myers Squibb
Bayer HealthCare Pharmaceutical, Inc./Onyx Pharmaceuticals, Inc.
Astellas US Pharma